Concepts (354)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Smoking Cessation | 21 | 2020 | 826 | 5.75 | Why? |
| Smoking Prevention | 10 | 2019 | 116 | 4.73 | Why? |
| Smokers | 12 | 2020 | 550 | 4.29 | Why? |
| Hong Kong | 57 | 2021 | 3361 | 3.44 | Why? |
| Smoking | 23 | 2021 | 3358 | 2.95 | Why? |
| Happiness | 5 | 2021 | 111 | 1.70 | Why? |
| Tobacco Smoke Pollution | 6 | 2018 | 181 | 1.57 | Why? |
| Tobacco Use Disorder | 4 | 2020 | 163 | 1.57 | Why? |
| Counseling | 5 | 2018 | 747 | 1.52 | Why? |
| Tobacco Products | 4 | 2019 | 245 | 1.35 | Why? |
| Electronic Nicotine Delivery Systems | 4 | 2018 | 561 | 1.29 | Why? |
| Health Promotion | 5 | 2018 | 2020 | 1.13 | Why? |
| Nicotine | 3 | 2020 | 213 | 1.07 | Why? |
| Intention | 6 | 2019 | 1380 | 1.06 | Why? |
| Vaping | 3 | 2019 | 436 | 1.04 | Why? |
| Adolescent Behavior | 3 | 2018 | 400 | 0.99 | Why? |
| Tobacco | 3 | 2020 | 274 | 0.98 | Why? |
| Psychometrics | 3 | 2019 | 1269 | 0.95 | Why? |
| Tobacco Smoking | 4 | 2021 | 349 | 0.94 | Why? |
| Capacity Building | 2 | 2018 | 683 | 0.92 | Why? |
| Cigarette Smoking | 3 | 2018 | 337 | 0.79 | Why? |
| Telephone | 3 | 2017 | 1705 | 0.78 | Why? |
| Motivational Interviewing | 1 | 2019 | 55 | 0.76 | Why? |
| Attitude to Health | 3 | 2019 | 2002 | 0.75 | Why? |
| Smoking Reduction | 1 | 2017 | 4 | 0.74 | Why? |
| Smoke-Free Policy | 5 | 2019 | 52 | 0.72 | Why? |
| Alcohol Drinking | 5 | 2020 | 1663 | 0.72 | Why? |
| Tobacco Use | 3 | 2020 | 340 | 0.69 | Why? |
| Hotlines | 2 | 2020 | 337 | 0.67 | Why? |
| Smartphone | 2 | 2018 | 1840 | 0.65 | Why? |
| Airway Obstruction | 1 | 2019 | 182 | 0.64 | Why? |
| Cause of Death | 4 | 2018 | 4823 | 0.64 | Why? |
| Information Technology | 1 | 2019 | 278 | 0.64 | Why? |
| Online Systems | 1 | 2018 | 240 | 0.61 | Why? |
| Volunteers | 2 | 2018 | 601 | 0.60 | Why? |
| Health Knowledge, Attitudes, Practice | 8 | 2021 | 8811 | 0.59 | Why? |
| Alcoholic Intoxication | 1 | 2015 | 77 | 0.58 | Why? |
| Exercise | 8 | 2019 | 6771 | 0.56 | Why? |
| Awareness | 1 | 2019 | 529 | 0.53 | Why? |
| Health Behavior | 6 | 2021 | 4449 | 0.53 | Why? |
| Health Literacy | 2 | 2021 | 1078 | 0.52 | Why? |
| Surveys and Questionnaires | 22 | 2021 | 43792 | 0.52 | Why? |
| Health Surveys | 4 | 2021 | 2841 | 0.52 | Why? |
| Ethanol | 1 | 2019 | 533 | 0.51 | Why? |
| Patient Compliance | 2 | 2020 | 1468 | 0.51 | Why? |
| Beer | 1 | 2012 | 14 | 0.51 | Why? |
| Lobbying | 1 | 2012 | 17 | 0.50 | Why? |
| Alcoholic Beverages | 1 | 2015 | 186 | 0.49 | Why? |
| Personal Satisfaction | 2 | 2021 | 1243 | 0.49 | Why? |
| Health Plan Implementation | 1 | 2018 | 571 | 0.49 | Why? |
| Taxes | 1 | 2012 | 66 | 0.47 | Why? |
| Wine | 1 | 2012 | 57 | 0.47 | Why? |
| Program Development | 1 | 2018 | 1089 | 0.46 | Why? |
| Family | 3 | 2021 | 2909 | 0.46 | Why? |
| Community Participation | 1 | 2018 | 605 | 0.46 | Why? |
| Single-Blind Method | 4 | 2020 | 1283 | 0.46 | Why? |
| Referral and Consultation | 2 | 2018 | 4816 | 0.45 | Why? |
| Male | 71 | 2021 | 367725 | 0.45 | Why? |
| Behavior, Addictive | 1 | 2018 | 535 | 0.44 | Why? |
| Hot Temperature | 1 | 2019 | 1299 | 0.44 | Why? |
| Female | 71 | 2021 | 380317 | 0.44 | Why? |
| Students | 5 | 2019 | 5255 | 0.43 | Why? |
| Nicotinic Agonists | 1 | 2011 | 56 | 0.43 | Why? |
| Abortion, Spontaneous | 1 | 2016 | 776 | 0.43 | Why? |
| Residence Characteristics | 2 | 2018 | 1927 | 0.43 | Why? |
| Blood Banks | 1 | 2016 | 535 | 0.42 | Why? |
| Cultural Characteristics | 2 | 2013 | 159 | 0.41 | Why? |
| Adolescent | 30 | 2021 | 86841 | 0.41 | Why? |
| Vascular Diseases | 1 | 2019 | 846 | 0.41 | Why? |
| Quality of Life | 4 | 2019 | 9820 | 0.40 | Why? |
| Logistic Models | 8 | 2018 | 9089 | 0.38 | Why? |
| Industry | 1 | 2012 | 347 | 0.38 | Why? |
| Adult | 46 | 2021 | 244371 | 0.38 | Why? |
| Cotinine | 2 | 2018 | 22 | 0.37 | Why? |
| Obesity | 5 | 2018 | 7388 | 0.37 | Why? |
| Menopause | 1 | 2010 | 136 | 0.37 | Why? |
| Leukocyte Count | 1 | 2018 | 3178 | 0.36 | Why? |
| Treatment Refusal | 1 | 2011 | 211 | 0.36 | Why? |
| Patient Education as Topic | 1 | 2018 | 1476 | 0.36 | Why? |
| Environmental Exposure | 2 | 2018 | 1558 | 0.35 | Why? |
| Humans | 89 | 2021 | 930598 | 0.33 | Why? |
| Public Opinion | 1 | 2017 | 1165 | 0.33 | Why? |
| Socioeconomic Factors | 6 | 2021 | 8495 | 0.33 | Why? |
| Cross-Sectional Studies | 18 | 2021 | 53120 | 0.33 | Why? |
| Health Communication | 1 | 2018 | 1120 | 0.33 | Why? |
| Mobile Applications | 2 | 2019 | 3032 | 0.32 | Why? |
| Mental Health | 5 | 2021 | 15770 | 0.31 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2018 | 1692 | 0.31 | Why? |
| Dyspnea | 1 | 2019 | 3847 | 0.29 | Why? |
| Middle Aged | 43 | 2021 | 270681 | 0.29 | Why? |
| Neck Pain | 1 | 2006 | 126 | 0.29 | Why? |
| Parents | 2 | 2018 | 2758 | 0.28 | Why? |
| Family Relations | 2 | 2018 | 288 | 0.28 | Why? |
| Women's Health | 1 | 2010 | 444 | 0.28 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.28 | Why? |
| China | 17 | 2020 | 50654 | 0.28 | Why? |
| Young Adult | 19 | 2021 | 93724 | 0.28 | Why? |
| Chronic Disease | 1 | 2019 | 5139 | 0.28 | Why? |
| Social Class | 5 | 2019 | 1360 | 0.27 | Why? |
| Health Status | 4 | 2021 | 3259 | 0.27 | Why? |
| Vulnerable Populations | 1 | 2018 | 3099 | 0.27 | Why? |
| Pilot Projects | 4 | 2020 | 5182 | 0.26 | Why? |
| Reproducibility of Results | 5 | 2019 | 11304 | 0.26 | Why? |
| Prevalence | 12 | 2021 | 25773 | 0.25 | Why? |
| Communication | 3 | 2021 | 5206 | 0.25 | Why? |
| Obesity, Abdominal | 2 | 2017 | 167 | 0.25 | Why? |
| Cohort Studies | 15 | 2019 | 36005 | 0.23 | Why? |
| Vaccines | 1 | 2021 | 3692 | 0.23 | Why? |
| Odds Ratio | 7 | 2018 | 5861 | 0.23 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 3832 | 0.22 | Why? |
| Biological Specimen Banks | 3 | 2018 | 1142 | 0.22 | Why? |
| Medication Adherence | 1 | 2011 | 1270 | 0.22 | Why? |
| Mendelian Randomization Analysis | 3 | 2018 | 317 | 0.21 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.21 | Why? |
| Exome | 2 | 2018 | 207 | 0.21 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.20 | Why? |
| Sex Distribution | 2 | 2018 | 2083 | 0.20 | Why? |
| Acceptance and Commitment Therapy | 1 | 2018 | 19 | 0.19 | Why? |
| Craving | 1 | 2019 | 43 | 0.19 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.19 | Why? |
| Nerve Growth Factors | 1 | 2018 | 30 | 0.19 | Why? |
| Tibial Arteries | 1 | 2018 | 16 | 0.19 | Why? |
| Tobacco, Smokeless | 1 | 2018 | 11 | 0.19 | Why? |
| Serpins | 1 | 2018 | 67 | 0.19 | Why? |
| Learning | 2 | 2017 | 1181 | 0.19 | Why? |
| Eye Proteins | 1 | 2018 | 42 | 0.19 | Why? |
| Spirometry | 2 | 2019 | 524 | 0.18 | Why? |
| Self Report | 4 | 2019 | 3802 | 0.18 | Why? |
| Cardiovascular Diseases | 6 | 2019 | 11497 | 0.18 | Why? |
| Hand Strength | 1 | 2019 | 202 | 0.18 | Why? |
| Eggs | 1 | 2018 | 43 | 0.18 | Why? |
| Actigraphy | 1 | 2018 | 102 | 0.18 | Why? |
| Counselors | 1 | 2018 | 37 | 0.18 | Why? |
| Vitamin E | 1 | 2018 | 128 | 0.18 | Why? |
| Sleep Hygiene | 1 | 2018 | 91 | 0.18 | Why? |
| Water Pipe Smoking | 1 | 2018 | 47 | 0.17 | Why? |
| Menarche | 1 | 2017 | 21 | 0.17 | Why? |
| Schools | 3 | 2019 | 4187 | 0.17 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.17 | Why? |
| Inservice Training | 2 | 2016 | 477 | 0.17 | Why? |
| Brachial Artery | 1 | 2018 | 107 | 0.17 | Why? |
| Tobacco Use Cessation | 1 | 2017 | 52 | 0.17 | Why? |
| Program Evaluation | 4 | 2019 | 1929 | 0.17 | Why? |
| Behavior Therapy | 1 | 2020 | 235 | 0.17 | Why? |
| Underage Drinking | 1 | 2017 | 30 | 0.17 | Why? |
| Vitamin A | 1 | 2018 | 188 | 0.17 | Why? |
| Cholesterol | 2 | 2018 | 660 | 0.16 | Why? |
| Diet | 3 | 2018 | 2052 | 0.16 | Why? |
| Awards and Prizes | 1 | 2018 | 101 | 0.16 | Why? |
| Text Messaging | 2 | 2018 | 389 | 0.16 | Why? |
| Aged | 26 | 2021 | 215776 | 0.16 | Why? |
| Problem Behavior | 1 | 2018 | 176 | 0.16 | Why? |
| Prospective Studies | 8 | 2019 | 43301 | 0.16 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.16 | Why? |
| Fibroblast Growth Factors | 1 | 2017 | 119 | 0.16 | Why? |
| Social Media | 1 | 2018 | 5798 | 0.16 | Why? |
| Motivation | 3 | 2018 | 1640 | 0.16 | Why? |
| Child Behavior | 1 | 2019 | 266 | 0.15 | Why? |
| Organizational Culture | 1 | 2019 | 395 | 0.15 | Why? |
| Family Health | 1 | 2021 | 731 | 0.15 | Why? |
| Education | 2 | 2017 | 434 | 0.15 | Why? |
| Vascular Stiffness | 1 | 2018 | 264 | 0.14 | Why? |
| Proportional Hazards Models | 5 | 2018 | 6543 | 0.14 | Why? |
| Diabetic Nephropathies | 1 | 2018 | 315 | 0.14 | Why? |
| Polymorphism, Single Nucleotide | 5 | 2018 | 3607 | 0.14 | Why? |
| Risk-Taking | 1 | 2018 | 508 | 0.13 | Why? |
| Follow-Up Studies | 8 | 2019 | 17020 | 0.13 | Why? |
| Costs and Cost Analysis | 1 | 2018 | 694 | 0.13 | Why? |
| Age Factors | 4 | 2019 | 21039 | 0.13 | Why? |
| Cluster Analysis | 3 | 2018 | 3001 | 0.13 | Why? |
| Adaptor Proteins, Signal Transducing | 1 | 2017 | 502 | 0.13 | Why? |
| Adipokines | 1 | 2013 | 87 | 0.12 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.12 | Why? |
| Nursing Staff, Hospital | 1 | 2007 | 1554 | 0.12 | Why? |
| Body Mass Index | 4 | 2018 | 4306 | 0.12 | Why? |
| Peer Group | 1 | 2017 | 402 | 0.12 | Why? |
| Ascorbic Acid | 1 | 2018 | 676 | 0.12 | Why? |
| Peripheral Arterial Disease | 1 | 2018 | 471 | 0.12 | Why? |
| Social Workers | 1 | 2016 | 269 | 0.11 | Why? |
| Risk Factors | 13 | 2018 | 71621 | 0.11 | Why? |
| Saliva | 2 | 2018 | 4679 | 0.11 | Why? |
| Population Surveillance | 3 | 2018 | 4967 | 0.11 | Why? |
| Population Health | 1 | 2018 | 504 | 0.11 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.11 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.11 | Why? |
| Professional-Patient Relations | 1 | 2016 | 426 | 0.11 | Why? |
| Alanine Transaminase | 1 | 2017 | 1329 | 0.10 | Why? |
| Coronary Disease | 2 | 2017 | 645 | 0.10 | Why? |
| Translating | 1 | 2010 | 80 | 0.10 | Why? |
| Advisory Committees | 1 | 2017 | 1418 | 0.10 | Why? |
| Myocardial Ischemia | 1 | 2017 | 781 | 0.10 | Why? |
| Life Style | 3 | 2018 | 2708 | 0.10 | Why? |
| Perception | 2 | 2018 | 2827 | 0.10 | Why? |
| Housing | 1 | 2017 | 1146 | 0.10 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.10 | Why? |
| Intention to Treat Analysis | 1 | 2011 | 673 | 0.10 | Why? |
| Longitudinal Studies | 3 | 2017 | 9893 | 0.10 | Why? |
| Antioxidants | 1 | 2018 | 1593 | 0.09 | Why? |
| Child | 9 | 2019 | 70012 | 0.09 | Why? |
| Attitude of Health Personnel | 1 | 2007 | 4741 | 0.09 | Why? |
| Genetic Predisposition to Disease | 3 | 2017 | 4027 | 0.09 | Why? |
| Nursing Methodology Research | 1 | 2007 | 13 | 0.09 | Why? |
| Risk Assessment | 5 | 2019 | 25439 | 0.09 | Why? |
| Commerce | 1 | 2017 | 1109 | 0.08 | Why? |
| Waist Circumference | 2 | 2018 | 199 | 0.08 | Why? |
| Clinical Protocols | 1 | 2018 | 2734 | 0.08 | Why? |
| Asthma | 2 | 2017 | 4383 | 0.08 | Why? |
| Nursing Assessment | 1 | 2007 | 72 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Treatment Outcome | 4 | 2018 | 51732 | 0.08 | Why? |
| Nursing Evaluation Research | 1 | 2007 | 176 | 0.08 | Why? |
| Nursing Education Research | 1 | 2007 | 177 | 0.08 | Why? |
| Qualitative Research | 1 | 2018 | 4337 | 0.08 | Why? |
| Research Design | 2 | 2019 | 5830 | 0.07 | Why? |
| Fear | 1 | 2021 | 3607 | 0.07 | Why? |
| Education, Nursing, Continuing | 1 | 2007 | 129 | 0.07 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.07 | Why? |
| Triglycerides | 2 | 2018 | 478 | 0.07 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2018 | 3129 | 0.07 | Why? |
| Internationality | 1 | 2017 | 3297 | 0.07 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.07 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2018 | 6166 | 0.07 | Why? |
| Genetic Association Studies | 2 | 2017 | 559 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.07 | Why? |
| Internet | 2 | 2021 | 6204 | 0.07 | Why? |
| Retrospective Studies | 4 | 2020 | 105322 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2017 | 2320 | 0.06 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.06 | Why? |
| Adiposity | 2 | 2017 | 329 | 0.06 | Why? |
| Aerosols | 1 | 2019 | 5393 | 0.06 | Why? |
| Mutation, Missense | 2 | 2018 | 863 | 0.06 | Why? |
| Lung Neoplasms | 1 | 2019 | 3228 | 0.06 | Why? |
| Combined Modality Therapy | 1 | 2011 | 3395 | 0.06 | Why? |
| Heart Rate | 1 | 2011 | 1527 | 0.06 | Why? |
| Hospitals, Urban | 1 | 2007 | 950 | 0.05 | Why? |
| Health Status Disparities | 1 | 2019 | 4072 | 0.05 | Why? |
| Masks | 2 | 2021 | 8528 | 0.05 | Why? |
| Severe Acute Respiratory Syndrome | 4 | 2006 | 12361 | 0.05 | Why? |
| Epidemiologic Methods | 1 | 2003 | 392 | 0.05 | Why? |
| Diabetes Mellitus | 2 | 2011 | 8207 | 0.05 | Why? |
| Ankle Brachial Index | 1 | 2018 | 53 | 0.05 | Why? |
| Educational Measurement | 1 | 2007 | 930 | 0.05 | Why? |
| Dietary Fiber | 1 | 2018 | 73 | 0.05 | Why? |
| Nurse's Role | 1 | 2007 | 614 | 0.05 | Why? |
| Australasia | 1 | 2018 | 89 | 0.05 | Why? |
| Waist-Hip Ratio | 1 | 2017 | 50 | 0.04 | Why? |
| Malonyl Coenzyme A | 1 | 2017 | 1 | 0.04 | Why? |
| Glucokinase | 1 | 2017 | 2 | 0.04 | Why? |
| Glucose-6-Phosphate | 1 | 2017 | 5 | 0.04 | Why? |
| Carnitine O-Palmitoyltransferase | 1 | 2017 | 11 | 0.04 | Why? |
| Mitogen-Activated Protein Kinase 10 | 1 | 2017 | 6 | 0.04 | Why? |
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 54 | 0.04 | Why? |
| Tumor Suppressor Proteins | 1 | 2018 | 165 | 0.04 | Why? |
| Physical Therapy Modalities | 1 | 2006 | 1090 | 0.04 | Why? |
| Television | 1 | 2019 | 224 | 0.04 | Why? |
| Prognosis | 2 | 2018 | 32490 | 0.04 | Why? |
| Pulse Wave Analysis | 1 | 2018 | 221 | 0.04 | Why? |
| Databases, Factual | 1 | 2012 | 6248 | 0.04 | Why? |
| Stress, Psychological | 1 | 2020 | 10231 | 0.04 | Why? |
| Cost-Benefit Analysis | 1 | 2007 | 2259 | 0.04 | Why? |
| Fathers | 1 | 2017 | 114 | 0.04 | Why? |
| Biomarkers | 2 | 2017 | 23361 | 0.04 | Why? |
| Sodium | 1 | 2018 | 309 | 0.04 | Why? |
| Needs Assessment | 1 | 2007 | 2352 | 0.04 | Why? |
| Hypercholesterolemia | 1 | 2018 | 175 | 0.04 | Why? |
| Potassium | 1 | 2018 | 325 | 0.04 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Vital Capacity | 1 | 2017 | 399 | 0.04 | Why? |
| Regression Analysis | 2 | 2017 | 2484 | 0.04 | Why? |
| Fatty Acids | 1 | 2017 | 238 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Public Sector | 1 | 2017 | 204 | 0.04 | Why? |
| Lipase | 1 | 2017 | 153 | 0.04 | Why? |
| Video Games | 1 | 2019 | 270 | 0.04 | Why? |
| Death | 1 | 2018 | 334 | 0.04 | Why? |
| Public Health Practice | 1 | 2003 | 945 | 0.03 | Why? |
| Respiratory Sounds | 1 | 2017 | 294 | 0.03 | Why? |
| Forced Expiratory Volume | 1 | 2017 | 632 | 0.03 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Pregnancy | 1 | 2016 | 23879 | 0.03 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.03 | Why? |
| Curriculum | 1 | 2007 | 3083 | 0.03 | Why? |
| Stroke | 2 | 2018 | 8839 | 0.03 | Why? |
| Self Efficacy | 1 | 2018 | 717 | 0.03 | Why? |
| Health Policy | 1 | 2012 | 6242 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2018 | 88759 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Focus Groups | 1 | 2016 | 811 | 0.03 | Why? |
| Far East | 1 | 2011 | 125 | 0.03 | Why? |
| Clinical Competence | 1 | 2007 | 3263 | 0.03 | Why? |
| Asia | 1 | 2018 | 2399 | 0.03 | Why? |
| Confidence Intervals | 1 | 2013 | 744 | 0.03 | Why? |
| Cardiovascular System | 1 | 2018 | 750 | 0.03 | Why? |
| Hand Hygiene | 1 | 2021 | 1493 | 0.03 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.02 | Why? |
| Depression | 1 | 2013 | 14116 | 0.02 | Why? |
| Public Policy | 1 | 2021 | 1894 | 0.02 | Why? |
| Lung | 1 | 2017 | 31049 | 0.02 | Why? |
| Cooperative Behavior | 1 | 2016 | 1216 | 0.02 | Why? |
| Physical Fitness | 1 | 2011 | 334 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Poisson Distribution | 1 | 2008 | 348 | 0.02 | Why? |
| Mothers | 1 | 2017 | 1624 | 0.02 | Why? |
| Body Composition | 1 | 2011 | 414 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2020 | 3228 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.02 | Why? |
| Models, Statistical | 1 | 2003 | 5312 | 0.02 | Why? |
| Neoplasms | 1 | 2013 | 17251 | 0.02 | Why? |
| Disease Outbreaks | 2 | 2003 | 27595 | 0.02 | Why? |
| New Zealand | 1 | 2011 | 2073 | 0.02 | Why? |
| Workplace | 1 | 2017 | 2075 | 0.02 | Why? |
| Blood Glucose | 1 | 2018 | 3642 | 0.02 | Why? |
| Muscle, Skeletal | 1 | 2011 | 915 | 0.02 | Why? |
| SARS Virus | 2 | 2004 | 13021 | 0.02 | Why? |
| Mathematics | 1 | 2003 | 65 | 0.02 | Why? |
| Influenza, Human | 1 | 2008 | 10779 | 0.02 | Why? |
| Practice Guidelines as Topic | 1 | 2007 | 15421 | 0.01 | Why? |
| Vitamin D | 1 | 2017 | 2904 | 0.01 | Why? |
| Influenza B virus | 1 | 2008 | 815 | 0.01 | Why? |
| Aging | 1 | 2018 | 3581 | 0.01 | Why? |
| Stochastic Processes | 1 | 2003 | 369 | 0.01 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.01 | Why? |
| Likelihood Functions | 1 | 2003 | 719 | 0.01 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.01 | Why? |
| Infant | 2 | 2017 | 30274 | 0.01 | Why? |
| Probability | 1 | 2003 | 923 | 0.01 | Why? |
| Child, Preschool | 2 | 2018 | 36283 | 0.01 | Why? |
| Australia | 1 | 2011 | 6306 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Hypertension | 1 | 2018 | 8895 | 0.01 | Why? |
| Influenza A virus | 1 | 2008 | 2234 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2006 | 51949 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Survival Analysis | 1 | 2008 | 7592 | 0.01 | Why? |
| Age Distribution | 1 | 2003 | 3567 | 0.01 | Why? |
| Inflammation | 1 | 2013 | 13255 | 0.01 | Why? |
| Seroepidemiologic Studies | 1 | 2006 | 10017 | 0.01 | Why? |
| Patient Isolation | 1 | 2003 | 3182 | 0.01 | Why? |
| Survival Rate | 1 | 2003 | 9206 | 0.01 | Why? |
| Quarantine | 2 | 2003 | 18418 | 0.00 | Why? |
| Disease Progression | 1 | 2003 | 13580 | 0.00 | Why? |
| Comorbidity | 1 | 2008 | 34796 | 0.00 | Why? |
| Contact Tracing | 1 | 2003 | 8448 | 0.00 | Why? |
| Cross Infection | 1 | 2003 | 8675 | 0.00 | Why? |
| Immunoglobulin G | 1 | 2004 | 21571 | 0.00 | Why? |
| Global Health | 1 | 2003 | 13911 | 0.00 | Why? |
| Coronavirus | 1 | 2006 | 18339 | 0.00 | Why? |
| Infection Control | 1 | 2003 | 23131 | 0.00 | Why? |
| Hospitalization | 1 | 2003 | 54280 | 0.00 | Why? |